Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1 2Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Recruiting 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Breast Cancer Female 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Thioctic Acid × Clear all
NCT06703593 2025-10-01

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

British University In Egypt

Phase 2 Completed
80 enrolled
Breast

Breast Cancer Female

NCT05231980 2023-07-20

Efficacy of Pentoxifylline and Alpha Lipoic Acid in PCOS Resistant to Clomiphene Citrate

Ain Shams University

Phase 2 Completed
120 enrolled
Gynecologic

Polycystic Ovary Syndrome, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡